Search Results
Colon Cancer Vaccine on the Horizon
Researchers hope that a protein found in the intestines could lead to the discovery of a vaccine for colon cancer, Reuters reported Tuesday.
A study published in the Journal of the National Cancer Institute detailed how mice were immunized with the protein and subsequently infected with colon tumors.
These mice had fewer tumors spread to the lung […]
New Breast Cancer Center Will Help Women Better Understand
After losing her mother to breast cancer as a child and then battling the disease herself, Khristi Rogers of Mount Pleasant, Miss., considered herself a savvy patient.
Diagnosed in 2002, she studied her treatment options and chose limited surgery combined with radiation and medication, rather than mastectomy.
She researched genetic testing.
She didn’t miss followup appointments.
“I knew I […]
Surviving Colon Cancer Is Tied to Family History of It
People with a family history of colon cancer carry the emotional burden of knowing they have twice the risk of developing the disease themselves. But a new study may ease some of their anxiety. Patients with a family history of colon cancer, the researchers found, are also more likely to survive it.
The surprising paradox, being […]
ImClone Says Its Cancer Drug Works as Initial Treatment
Two biotechnology giants did battle here at the nation’s largest cancer conference over the weekend. And both remained standing.
Data presented here could increase sales of the drug Erbitux, developed by ImClone Systems, by allowing it to be used as an initial treatment for patients with advanced lung and colorectal cancers. That is now the domain […]
Erbitux Works Well for Two-Thirds of Colon Cancer Patients
Colon cancer patients who have the normal version of a particular gene are more likely to benefit from a combination treatment that includes adding the targeted therapy Erbitux to chemotherapy.
Some two-thirds of colon cancer patients have the normal, or “wild-type” form of the gene, according to the new study.
Celebrex May Reduce Levels of Lung Cancer Biomarker
A widely prescribed pain reliever may one day have value in helping to prevent lung cancer.
Researchers report that Celebrex (celecoxib), the last remaining cox-2 inhibitor on the U.S. market, may reduce levels of a biomarker indicating risk for this deadly disease. The team presented its findings Sunday at the American Society of Clinical Oncology annual […]
Repeat Colonoscopies Underused in High-Risk Patients
The people who most need to have repeat colonoscopies to detect precancerous growths are less likely to get the potentially lifesaving procedures, new research shows.
“We are doing more colonoscopies among the low-risk groups and not enough among the high-risk,” study author Dr. Adeyinka Laiyemo, a cancer prevention research fellow at the National Cancer Institute, said […]
Ning Wong Of Fox Chase Cancer Center Receives ASCO Cancer Foundation Career Development Award
The American Society of Clinical Oncology Cancer Foundation has selected Yu-Ning Wong, M.D., M.S.C.E., of Fox Chase Cancer Center, as one of 13 clinicians to receive a 2008 Career Development Award. Career Development Awards are presented to physicians in their second, third or fourth year as full-time faculty members in an academic setting. This award […]
Vitamin D may help curb breast cancer, study finds
Breast cancer patients with low levels of vitamin D were much more likely to die of the disease or have it spread than patients getting enough of the nutrient, a study found — adding to evidence the “sunshine vitamin” has anti-cancer benefits. The results are sure to renew arguments about whether a little more sunshine […]